Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC-Reference-Cited by-同舟云学术

Nrf2 Mutation/Activation Is Dispensable for the Development of Chemically Induced Mouse HCC

Published:2022 Issue:1 Volume:13 Page:113-127
ISSN:2352-345X
Container-title:Cellular and Molecular Gastroenterology and Hepatology
language:en
Short-container-title:Cellular and Molecular Gastroenterology and Hepatology

Author:

Mattu Sandra,Zavattari Patrizia,Kowalik Marta Anna,Serra Marina,Sulas Pia,Pal Rajesh,Puliga Elisabetta,Sutti Salvatore,Foglia Beatrice,Parola Maurizio,Albano Emanuele,Giordano Silvia,Perra Andrea,Columbano Amedeo^ORCID

Funder

Associazione Italiana per la Ricerca sul Cancro

Publisher

Elsevier BV

Subject

Gastroenterology,Hepatology

Reference47 articles.

1. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries;Sung;CA Cancer J Clin,2021

2. Dual roles of Nrf2 in cancer;Lau;Pharmacol Res,2008

3. NRF2 and cancer: the good, the bad and the importance of context;Sporn;Nat Rev Cancer,2012

4. The dual roles of NRF2 in cancer;Menegon;Trends Mol Med,2016

5. Nrf2-Keap1 defines a physiologically important stress response mechanism;Motohashi;Trends Mol Med,2004

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. The multifaceted perspectives on the regulation of lncRNAs in hepatocellular carcinoma ferroptosis: from bench-to-bedside;Clinical and Experimental Medicine;2024-07-03

2. Past, present, and future of chemically induced hepatocarcinogenesis rodent models: Perspectives concerning classic and new cancer hallmarks;Life Sciences;2023-10

3. Nucleolar HEAT Repeat Containing 1 Up-regulated by the Mechanistic Target of Rapamycin Complex 1 Signaling Promotes Hepatocellular Carcinoma Growth by Dominating Ribosome Biogenesis and Proteome Homeostasis;Gastroenterology;2023-09

4. Nrf2 induces malignant transformation of hepatic progenitor cells by inducing β-catenin expression;Redox Biology;2022-11

5. Downregulation of CYP39A1 Serves as a Novel Biomarker in Hepatocellular Carcinoma with Worse Clinical Outcome;Oxidative Medicine and Cellular Longevity;2021-12-31